Expert pathology and molecular oncology consultation for complex diagnostic cases. Provides second opinions and treatment guidance based on comprehensive genomic analysis.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GENETRON HEALTH (BEIJING) CO., LTD
China · 2 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 3 relevant products
AcroCyte Therapeutics, Inc.
Taiwan · 1 relevant product
Beijing Diagreat Biotechnologies Co., Ltd
China · 2 relevant products
NOROVA
China · 2 relevant products
Biopsense Oy
Finland · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 2 relevant products
Accurate International Biotechnology (Guangzhou) Co.,Ltd
China · 1 relevant product
GeneCker Co., Ltd.
South Korea · 1 relevant product
EPS Smart Healthcare Technology(Shenzhen) Co.,Ltd
China · 1 relevant product
27 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 48 closest product alternatives
GENETRON HEALTH (BEIJING) CO., LTD · China
Digital pathology and tissue analysis service for cancer specimen evaluation. Integrates imaging and genomic data for comprehensive diagnosis. Provides expert interpretation and clinical recommendations.
BioChain (Beijing) Science & Technology. Inc. · China
Medical advisory service for cancer risk assessment and early detection strategy development. This service integrates diagnostic testing results with clinical decision support for patient management. The service is provided in collaboration with partner medical institutions.
GENETRON HEALTH (BEIJING) CO., LTD · China
Professional genomic analysis and interpretation service for clinical samples. Provides comprehensive mutation profiling and detailed clinical reports. Supports precision medicine and personalized treatment planning.
AcroCyte Therapeutics, Inc. · Taiwan
A clinical service that provides personalized treatment planning using patient-derived 3D cell culture models. The service leverages cultured patient cells to enable precision medicine approaches in cancer care. It supports clinicians in making informed treatment decisions based on individual patient cell behavior.
Beijing Diagreat Biotechnologies Co., Ltd · China
Comprehensive genetic testing service supporting precision drug therapy and personalized medicine applications. Integrates molecular analysis with therapeutic drug monitoring for comprehensive patient profiling.
BioChain (Beijing) Science & Technology. Inc. · China
Clinical laboratory testing service for colorectal cancer early detection using gene methylation methodology. This service is provided through affiliated medical testing laboratories with continuous proficiency certification. The service is integrated into hospital networks and supported by medical insurance coverage.
NOROVA · China
Personalized precision medicine service for malignant tumors using organoid technology. Enables accurate diagnosis and treatment planning through patient-derived tumor models. Supports clinical decision-making for oncology patients.
Biopsense Oy · Finland
Comprehensive diagnostic service utilizing liquid biopsy technology for cancer detection, monitoring, and treatment response evaluation. Supports oncologists in selecting optimal cancer medications and detecting drug resistance through frequent, non-invasive blood sampling.
NOROVA · China
Scientific research service providing tumor organoid development and analysis for research institutions and clinical centers. Supports preclinical and translational oncology research. Facilitates drug efficacy testing and personalized treatment validation.
BioChain (Beijing) Science & Technology. Inc. · China
Comprehensive laboratory testing service for hepatocellular carcinoma early detection and surveillance. This service integrates gene methylation testing with clinical assessment protocols for liver cancer screening. The service is accredited through continuous external quality assessment programs.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Comprehensive precision medicine solutions covering over 2000 service items across oncology, maternal-child health, cardiovascular, and infectious diseases. Services include disease screening, early diagnosis, molecular profiling, drug sensitivity selection, efficacy monitoring, and prognosis assessment.
Accurate International Biotechnology (Guangzhou) Co.,Ltd · China
A personalized testing service using patient-derived organoids to evaluate drug efficacy and identify optimal therapeutic candidates for individual cancer treatment protocols.
36 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products